Acupuncture And Inflammatory Status In Breast Cancer Patients With Climateric Syndrome.

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

July 2, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

March 24, 2023

Conditions
Breast Cancer
Interventions
OTHER

Post menopausal breast cancer patients

"All selected patients will undergo peripheral blood samplingfor the evaluation of inflammatory biomarkers and must have agreed to store and use part of their sample for research purposes.~A panel of inflammatory cytokines (IFNγ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-22, TNFα) will be detected by ELISA assay. Other biomarkers such as RANKL, OPG, Vitamin D levels, CTX, PTH will be evaluated by immunoenzymatic assays. In addition, mirNAs as mir-16 and mir-378 will be evaluated by RT-PCR. Glucose metabolic markers such as fasting glucose and insulin, HbA1c and other parameters such as calcemia, PTH, c-telopeptide etc. will be collected.~In particular, the evaluation of the biomarkers will be done on plasma samples at different time points (previously the administration of 10 course of weekly acupuncture; at the end and 6 months after the end of acupuncture and at the time of symptoms recurrence."

Trial Locations (1)

47014

Irccs Irst, Meldola

All Listed Sponsors
lead

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER

NCT07137221 - Acupuncture And Inflammatory Status In Breast Cancer Patients With Climateric Syndrome. | Biotech Hunter | Biotech Hunter